Vol. 37 No. 5 (2020)
Parasitology

Echinococcus granulosus genotypes verified in human hydatid disease around the world. Systematic review

Carlos Manterola Delgado
Universidad de La Frontera
Bio
Claudio Rojas Pincheira
Universidad Austral de Chile
Bio
Armando Totomoch-Serra
Universidad de La Frontera
Bio
Nayely García Méndez
Universidad de La Frontera
Bio
Ángela Riffo-Campos
Universidad de La Frontera
Bio

Published 2020-11-04

How to Cite

1.
Manterola Delgado C, Rojas Pincheira C, Totomoch-Serra A, García Méndez N, Riffo-Campos Ángela. Echinococcus granulosus genotypes verified in human hydatid disease around the world. Systematic review. Rev. Chilena. Infectol. [Internet]. 2020 Nov. 4 [cited 2026 Jun. 28];37(5). Available from: https://revinf.cl/index.php/revinf/article/view/611

Abstract

Background: The evidence regarding genotypic characteristics of Echinococcus granulosus infection in humans worldwide is scarce. Aim: To develop a synthesis of the available evidence regarding genotypes of E. granulosus verified in humans worldwide. Material and Methods: Systematic review. Articles related with genotypes of E. granulosus, in humans, without language neither genotyped method restriction, published between 1990-2019 were included. A systematic in WoS, EMBASE, MEDLINE, SCOPUS, Trip Database, BIREME, SciELO, LILACS, IBECS, y OPS-OMS was carried out. In study variables were year of publication, country, number of samples, host and parasite organs, genotype identified, molecular marker and genes. Descriptive statistics were applied. Results: 701 related articles were identified; 62 fulfilled selection criteria, representing 1511 samples. The existing evidence was published between 1994 and 2019; and mainly comes from Iran (45.2%). The most commonly used sequencing method was PCR amplification and Sanger type sequencing with partial or total genotyping of the cox1 gene. Genotyped method most frequently used was cox1 (79,0%). Genotypes most frequently identified were G1 and G1/G3 complex (49.1% and 32.2%). Conclusions: Publications related to genotypes of Eg in humans are scarce, heterogeneous, and presenting differing results. Eg G1/G3 accounts for most of the global burden worldwide.